Clearside Biomedical, Inc. (CLSD)
收市後：
| 前收市價 | 1.3100 |
| 開市 | 1.3000 |
| 買盤 | 1.2700 x 100 |
| 賣出價 | 1.3300 x 100 |
| 今日波幅 | 1.3000 - 1.3400 |
| 52 週波幅 | 0.6500 - 2.1200 |
| 成交量 | |
| 平均成交量 | 379,738 |
| 市值 | 97.898M |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.5500 |
| 業績公佈日 | 2024年8月12日 - 2024年8月16日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 5.33 |
Insider MonkeyClearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript May 9, 2024 Clearside Biomedical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Clearside Biomedical First Quarter 2024 Financial Results and Corporate Update Conference Call. […]
ZacksClearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of -21.43% and 76.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Insider Monkey
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript March 13, 2024 Clearside Biomedical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Clearside Biomedical Q4 2023 Financial Results and Corporate Update Call. At this […]
